Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 28:9:236.
doi: 10.1186/s13014-014-0236-0.

Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer

Antonella Fogliata  1 , Po-Ming Wang  2 , Francesca Belosi  3 , Alessandro Clivio  3 , Giorgia Nicolini  3 , Eugenio Vanetti  3 , Luca Cozzi  3
Affiliations

Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer

Antonella Fogliata et al. Radiat Oncol. .

Abstract

Background: To evaluate in-silico the performance of a model-based optimization process for volumetric modulated arc therapy (RapidArc) applied to hepatocellular cancer treatments.

Patients and methods: 45 clinically accepted RA plans were selected to train a knowledge-based engine for the prediction of individualized dose-volume constraints. The model was validated on the same plans used for training (closed-loop) and on a set of other 25 plans not used for the training (open-loop). Dose prescription, target size, localization in the liver and arc configuration were highly variable in both sets to appraise the power of generalization of the engine. Quantitative dose volume histogram analysis was performed as well as a pass-fail analysis against a set of 8 clinical dose-volume objectives to appraise the quality of the new plans.

Results: Qualitative and quantitative equivalence was observed between the clinical and the test plans. The use of model-based optimization lead to a net improvement in the pass-rate of the clinical objectives compared to the plans originally optimized with standard methods (this pass-rate is the frequency of cases where the objectives are respected vs. the cases where constraints are not fulfilled). The increase in the pass-rate resulted of 2.0%, 0.9% and 0.5% in a closed-loop and two different open-loop validation experiments.

Conclusions: A knowledge-based engine for the optimization of RapidArc plans was tested and lead to clinically acceptable plans in the case of hepatocellular cancer radiotherapy. More studies are needed before a broad clinical use.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic representation of the model determination steps and of the PC method applied to DVH.
Figure 2
Figure 2
Examples of the model-based predictive objectives with the estimate range and automatic objectives (line objectives in this example).
Figure 3
Figure 3
The DVH for the population of 45 training patients for the PTV and OARs.
Figure 4
Figure 4
Scatter plot and regression lines for some of the various principal-component analysis.
Figure 5
Figure 5
Average DVH for the closed-loop validation experiment. The Orig lines are for the clinical plans while the Test lines for the model-based optimization.
Figure 6
Figure 6
Average DVH for the two open-loop validation experiments. The Orig lines are for the clinical plans, the Test lines for the model-based optimization with the same non-coplanar geometry, and the Test_2 lines for the simplified, coplanar only arc setting.
Figure 7
Figure 7
Shows the axial isodose distributions for 3 examples from the open-loop validation.
See this image and copyright information in PMC

References

    1. Chanyavanich V, Das S, Lee W, Lo W. Knowledge based IMRT treatment planning for prostate cancer. Med Phys. 2011;38:2515–2522. doi: 10.1118/1.3574874. - DOI - PubMed
    1. Zhu X, Ge Y, Li T, Thongphiew D, Yin FF, Wu Q. A planning quality evaluation tool for prostate adaptive IMRT based on machine learning. Med Phys. 2011;38:719–726. doi: 10.1118/1.3539749. - DOI - PubMed
    1. Yuan L, Ge Y, Lee W, Yin FF, Kirkpatrick J, Wu Q. Quantitative analysis of the factors which affect the inter-patient organ-at risk dose sparing variation in IMRT plans. Med Phys. 2012;39:6868–6878. doi: 10.1118/1.4757927. - DOI - PubMed
    1. Lian J, Yuan L, Ge Y, Chera B, Yoo D, Chang S, Yin F, Wu Q. Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an inter-technique and inter-institutional study. Med Phys. 2013;40:121704. doi: 10.1118/1.4828788. - DOI - PMC - PubMed
    1. Good D, Lo J, Lee R, Wu J, Yin FF, Das S. A knowledge based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning. Int J Radiat Oncol Biol Phys. 2013;87:176–181. doi: 10.1016/j.ijrobp.2013.03.015. - DOI - PubMed

MeSH terms